Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Neama M Lotfy"'
Autor:
Abdel‐Hameed Ibrahim Mohamed Ebid, Dina Ahmed Ismail, Neama M. Lotfy, Mohamed Adel Mahmoud, Magdy ELSharkawy
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:2255-2263
Autor:
Abdel-Hameed Ibrahim Mohamed, Ebid, Dina Ahmed, Ismail, Neama M, Lotfy, Mohamed Adel, Mahmoud, Magdy, ELSharkawy
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES.
Tacrolimus is a widely prescribed immunosuppressant agent for kidney transplantation. However, optimal dosing is challenging due to its narrow therapeutic index, potentially serious adverse effects, and wide inter-individual variability in pharmacoki
Autor:
Mervat Abo Gabal Hanan Farouk, Noran O. El Azizi Maryam A. Abdulrahman, Dalia Gamal Neama M. Lotfy
Publikováno v:
The Medical Journal of Cairo University. 88:2421-2429
Background: According to recent studies, in renal disease High Mobility Group Box 1 protien (HMGB1) levels in blood and urine, its expression in renal tissue, and its levels in the cytoplasm and extracellular medium are all elevated. Aim of Study: Wa
Autor:
Azza Omran, Tarek A. Hamdy, Heba M. Abdelmageed, Neama M Lotfy, Marwa M El-Begermy, Mohamed S. Taha, Badr Eldin Mostafa
Publikováno v:
The Egyptian Journal of Otolaryngology, Vol 32, Iss 4, Pp 279-286 (2016)
En Abstract Introduction The 5-year survival of patients with head and neck squamous cell carcinoma (HNSCC) has not changed dramatically over the last decades despite the use of various therapeutic modalities, including surgery and/or chemoradiation.
Publikováno v:
The Egyptian journal of immunology. 23(2)
The aim of the study was to evaluate the usefulness of presepsin as a diagnostic marker of sepsis in intensive care unit (ICU) patients. Presepsin was measured by a rapid method based on a chemiluminescent enzyme immunoassay (PATHFAST). The clinical
Publikováno v:
Egyptian Rheumatologist, Vol 39, Iss 3, Pp 175-178 (2017)
Aim of the work: To determine the frequency of anti-mutated citrullinated vimentin (anti-MCV) antibodies in chronic hepatitis C virus (HCV) patients and its relation to HCV associated arthritis. Patients and methods: The study included 60 HCV patient